Phosphatidylcholine and Chondroitin Sulphate in Peritoneal Dialysis Fluids to Preserve Membrane Function

Dobbie J.W. , Lloyd J.K. , Gall C.A. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1990; 6: 3–12.

Ota K. , Mineshima M. , Watanabe N. Functional deterioration of the peritoneum: does it occur in the absence of peritonitis? Nephrol Dial Transplant 1987; 2: 30–3.

Jörres A. , Topley N. , Gahl G.M. Biocompatibility of the peritoneal dialysis fluids. Int J Artif Organs 1992; 15: 79–83.

Lewis S. , Holmes C. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1991; 11: 14–21.

Miranda B. , Selgas R. , Munoz J. Peritoneal resting and heparinization as an effective treatment for ultrafiltration failure in CAPD patients. Perit Dial Int 1990; 10(Suppl 1): 121.

Gotloib L. , Shostack A. , Bar Sella P. Continuous mesothelial injury and regeneration during long-term peritoneal dialysis. Perit Dial Bull 1987; 7: 148–55.

Di Paolo N. , Sacchi G. , Vanni L. Implant of autologous mesothelial cells in animals and a peritoneal dialysis patient. Int J ArtifOrgans 1989; 12: 485–501.

Rain H. , Kessel M. Aspects of new solutions for peritoneal dialysis. Nephrol Dial Transplant 1987; 2: 67–72.

Hutchinson A.J. , Gokal R. Improved solutions for peritoneal dialysis: physiological calcium solutions, osmotic agents and buffers. Kidney Int 1992; 38(Suppl): S153–9.

Di Paolo N. , Buoncristiani U. , Gaggiotti E. Improvement of impaired ultrafiltration after addition of phosphatidylcholine in patients on CAPD. Perit Dial Bull 1986; 6: 44–5.

Breborowicz A. , Wieczorowska K. , Martis L. Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats. Nephron, in press.

Hills B.A. , Butler B.D. , Barrow R.E. Boundary lubrication imparted by pleural surfactants and their identification. J Appl Physiol 1982; 53: 463–9.

Grahame G.R. , Torchia M.G. , Dankewich K.A. Surface-active material in peritoneal effluent of CAPD patients. Perit Dial Bull 1985; 5: 109–11.

Di Paolo N. , Buoncristiani U. , Capotondo L. Phosphatidylcholine and peritoneal transport during peritoneal dialysis. Nephron 1986; 44: 365–70.

Struijk D.G. , Van der Reijden H.J. , Krediet R.T. Effect of phosphatidylcholine on peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis. Nephron 1989; 51: 577–8.

Dombros N. , Balaskas E. , Savidis N. Phosphatidylcholine increases ultrafiltration in CAPD patients. In: Avram M.M. , Giordano C. , eds. Ambulatory peritoneal dialysis. New York: Plenum Medical, 1990: 39–41.

Querques M. , Procaccini D.A. , Pappani A. Influence of phosphatidylcholine on ultrafiltration and solute transfer in CAPD patients. ASAIO Trans 1990; 36: M581–3.

Chan H. , Abraham G. , Oreopoulos D.G. Oral lecithin improves ultrafiltration in patients on peritoneal dialysis. Perit Dial Int 1989; 9: 203–5.

De Vecchi A. , Castelnovo C. , Guerra L. Phosphatidylcholine administration in continuous ambulatory peritoneal dialysis (CAPD) patients with reduced ultrafiltration. Perit Dial Int 1989; 9: 207–10.

Krack G. , Viglino G. , Cavalli P.L. Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992; 12: 359–64.

Dobbie J.W. , Pavlina T. , Lloyd J. Phosphatidylcholine synthesis by peritoneal mesothelium: its implications for peritoneal dialysis. Am J Kidney Dis 1988; 12: 31–6.

Dobbie J.W. , Lloyd J.K. Mesothelium secretes lamellar bodies in a similar manner to type II pneumocyte secretion of surfactant. Perit Dial Int 1989; 9: 215–19.

Di Paolo N. , Sacchi G. , De Mia M. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 204–11.

Ziegler C. , Torchia M. , Grahame G.R. Peritoneal surface-active material in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1989; 9: 47–9.

Lang J. , Harwood J. , Coles G. Changes in dialysate phospholipid content during CAPD. Perit Dial Int 1992; 12(Suppl 2): S13.

Breborowicz A. , Witowski J. , Knapowski J. Effect of phosphatidylcholine on the function of human mesothelial cells in vitro. Nephron 1993; 63: 15–20.

Rozga J. , Andersson R. , Srinivas U. Influence of phosphatidylcholine on intra-abdominal adhesion formation and peritoneal macrophages. Nephron 1990; 54: 134–8.

Ar'Rajab A. , Ahren B. , Rozga J. Phosphatidylcholine prevents postoperative peritoneal adhesions: an experimental study in therat. J Surg Res 1991; 50: 212–15.

Gagnon R.F. , Obst G. , Richards G.K. Effect of drug additives to peritoneal dialysis solutions on the viability and function of mouse peritoneal cells. Nephron 1990; 56: 201–5.

Staprans I. , Piel C.F. , Felts I.M. Analysis of selected plasma constituents in continuous ambulatory peritoneal dialysis fluid. Am J Kidney Dis 1986; VII: 490–4.

Davies M. , Stylianou E. , Yung S. Proteoglycans of CAPD-dialysate fluid and mesothelium. In: Coles G.A. , Davies M. , Williams J.D. , eds. CAPD: host defence, nutrition and ultrafiltration. Contrib Nephrol Basel, Karger, 1990; 85: 134–41.

Laurent T.C. , Fraser J.R. Hyaluronan. FASEB J 1992; 6: 2397–404.

Ohashi Y. , Honda A. , Iwai T. Stimulatory effect of vanadate on hyaluronic acid synthesis in mesothelial cells from rabbit pericardium. Biochemistry Int 1988; 16: 293–302.

Takasu Y. , Hasumi F. , Mori Y. Biosynthesis of glycosaminoglycans in peritoneal macrophages from the guinea pig. Biochim Biophys Acta 1982; 716: 316–23.

Hamura Y. , Ito A. , Okada Y. Hyaluronic acid metabolism in inflamed mesenterium of guinea pig. Res Commun Chem Pathol Pharmacol 1989; 66: 311–27.

Laurent U.B.G. , Reed R.K. Turnover of hyaluronan in the tissues. Adv Drug Delivery Rev, 1991; 7: 237–56.

Weigel P.H. , Fuller G.M. , LeBoeuf R.D. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 1986; 119: 219–34.

Bentley J.P. Rate of chondroitin sulfate in wound healing. Ann Surg 1967; 165: 186–91.

Couchman J.R. , Hook M. Proteoglycans and wound repair. In: Clark R.A.F. , Henson P.M. , eds. The molecular and cellular biology of wound repair. New York: Plenum, 1988: 437–70.

Mast B.A. , Flood L.C. , Haynes J.H. Hyaluronic acid is a major component of the matrix of fetal rabbit skin and wounds: implications for healing by regeneration. Matrix 1991; 11: 63–8.

King S.R. , Hickerson W.L. , Proctor K.G. Beneficial actions of exogenous hyaluronic acid on wound healing. Surgery 1991; 109: 76–84.

Abatangelo G. , Martelli M. , Vecchia P. Healing of hyaluronic acid-enriched wounds: histological observations. J Surg Res 1983; 35: 410–16.

Breborowicz A. , Wieczorowska K. , Knapowski J. Peroxidation of peritoneum during peritoneal dialysis. Perit Dial Int 1991; 11(Suppl 1): 32a.

Slater N.D. , Cope G.H. , Raftery A.T. Peritoneal ultrafiltration after chronic exposure to dialysis fluid. Perit Dial Int 1992; 12: 48–50.

Hiebert L. , Liu J.M. Protective action of polyelectrolytes on endothelium. Semin Thromb Hemost 1991; 17: 42–6.

Raepple E. , Hill H.U. , Loos M. Mode of interaction of different polyanions with the first (Cl,Cl-), the second (C2) and the fourth (C4) component of complement. Immunochemistry 1976; 13: 251–5.

Redini F. , Tixier J.M. , Petitou M. Inhibition of elastase by heparin and its derivatives. Biochem J 1988; 252: 515–19.

Baici A. , Bradamante P. Interaction of human leukocyte elastase and chondroitin sulphate. Chem Biol Interact 1984; 51: 1–11.

Fibbi G. , Vannucchi S. , Cavallini P. Involvement of chondroitin sulphate in preventing adhesive cellular interactions. Biochim Biophys Acta 1983; 762: 512–18.

Laurent T.C. , Frase J.R.E. , Pertoft H. Binding of hyaluronate and chondroitin sulphate to liver endothelial cells. Biochem J 1986; 234: 653–8.

Pipitone V.R. Chondroprotection with chondroitin sulphate. Drugs Exp Clin Res 1991; XVII: 3–7.

Paroli E. , Antonilli L. , Biffoni M. A pharmacological approach to glycosaminoglycans. Drugs Exp Clin Res 1991; 17: 9–19.

Hakansson L. , Hallgren R. , Venge P. Regulation of granulocyte function by hyaluronic acid. In vitro andin vivo effects on phagocytosis, locomotion and metabolism. J Clin Invest 1980; 66: 298–303.

Ahlgren T. , Jarstrand C. Hyaluronic acid enhances phagocytosis of human monocytes in uitro. J Clin Immunol 1984; 4: 246–9.

Westergren-Thorsson G. , Onnervik P.O. , Fransson L.A. Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans. J Cell Physiol 1991; 147: 523–30.

Gambaro G. , Cavazzana A.O. , Luzi P. Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 1992; 42: 285–91.